Mai Nguyen-Huynh to Tissue Plasminogen Activator
This is a "connection" page, showing publications Mai Nguyen-Huynh has written about Tissue Plasminogen Activator.
Connection Strength
2.667
-
Response by Flint et al to Letter Regarding Article, "Risk of Distal Embolization From tPA (Tissue-Type Plasminogen Activator) Administration Prior to Endovascular Stroke Treatment". Stroke. 2021 01; 52(1):e39-e40.
Score: 0.762
-
Risk of Distal Embolization From tPA (Tissue-Type Plasminogen Activator) Administration Prior to Endovascular Stroke Treatment. Stroke. 2020 09; 51(9):2697-2704.
Score: 0.741
-
Novel Telestroke Program Improves Thrombolysis for Acute Stroke Across 21 Hospitals of an Integrated Healthcare System. Stroke. 2018 01; 49(1):133-139.
Score: 0.617
-
Is hospitalization after TIA cost-effective on the basis of treatment with tPA? Neurology. 2005 Dec 13; 65(11):1799-801.
Score: 0.268
-
A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke. Stroke. 2011 Jul; 42(7):2013-8.
Score: 0.098
-
Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR). Stroke. 2011 Jun; 42(6):1658-64.
Score: 0.097
-
Comparative safety of tenecteplase vs alteplase for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2024 Jan; 33(1):107468.
Score: 0.058
-
Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e601S-e636S.
Score: 0.026